Efficacy and safety of biological therapy in patients with psoriasis and recent neoplasia: experience in real single-center clinical practice
- PMID: 36316510
- DOI: 10.1007/s00403-022-02443-y
Efficacy and safety of biological therapy in patients with psoriasis and recent neoplasia: experience in real single-center clinical practice
Keywords: Biological therapy; Malignancy; Psoriasis.
Similar articles
-
Cardiovascular risk factors influence response to biological therapies in psoriasis.J Am Acad Dermatol. 2015 Aug;73(2):327-9. doi: 10.1016/j.jaad.2015.04.041. J Am Acad Dermatol. 2015. PMID: 26183981 No abstract available.
-
Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study.J Am Acad Dermatol. 2015 Aug;73(2):237-41. doi: 10.1016/j.jaad.2015.04.023. Epub 2015 May 28. J Am Acad Dermatol. 2015. PMID: 26026334
-
Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study.Dermatol Ther. 2022 Jul;35(7):e15524. doi: 10.1111/dth.15524. Epub 2022 Apr 26. Dermatol Ther. 2022. PMID: 35439341 Free PMC article.
-
Practical experience of secukinumab in the treatment of psoriasis: experience from a single centre.Ir J Med Sci. 2021 May;190(2):639-641. doi: 10.1007/s11845-020-02336-x. Epub 2020 Aug 11. Ir J Med Sci. 2021. PMID: 32783092 Review.
-
[Psoriasis updates].Ann Dermatol Venereol. 2010 May;137(5 Suppl 1):1-4. doi: 10.1016/S0151-9638(10)70015-6. Ann Dermatol Venereol. 2010. PMID: 20510173 Review. French. No abstract available.
References
-
- Reid C, Griffiths CEM (2020) Psoriasis and treatment: past, present and future aspects. Acta Derm Venereol 100(3):69–79 - DOI
-
- Kaushik SB, Lebwohl MG (2019) Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol 80(1):27–40. https://doi.org/10.1016/j.jaad.2018.06.057 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical